Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 4, 2002
app pub date -
Oct 15, 2001
filing date -
Apr 9, 1997
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
DNA encoding a recombinant antibody molecule end-specific for an amyloid-.beta. peptide, pharmaceutical compositions thereof, and a method for preventing the accumulation of amyloid-.beta. peptides in the extracellular milieu of neurons by causing an end-specific antibody to come into contact with such amyloid-.beta. peptides. Such a method is useful for preventing or inhibiting progression of Alzheimer's Disease.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully